199 related articles for article (PubMed ID: 26280981)
1. Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.
Kuhnert G; Boellaard R; Sterzer S; Kahraman D; Scheffler M; Wolf J; Dietlein M; Drzezga A; Kobe C
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):249-258. PubMed ID: 26280981
[TBL] [Abstract][Full Text] [Related]
2. Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma.
Messerli M; Kotasidis F; Burger IA; Ferraro DA; Muehlematter UJ; Weyermann C; Kenkel D; von Schulthess GK; Kaufmann PA; Huellner MW
Br J Radiol; 2019 Apr; 92(1096):20180792. PubMed ID: 30673302
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction?
Voltin CA; Mettler J; Boellaard R; Kuhnert G; Dietlein M; Borchmann P; Drzezga A; Kobe C
Nucl Med Commun; 2019 Mar; 40(3):249-257. PubMed ID: 30461699
[TBL] [Abstract][Full Text] [Related]
4. Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods.
Brendle C; Kupferschläger J; Nikolaou K; la Fougère C; Gatidis S; Pfannenberg C
Eur J Radiol; 2015 Jan; 84(1):158-162. PubMed ID: 25467224
[TBL] [Abstract][Full Text] [Related]
5. The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on
Kurita Y; Ichikawa Y; Nakanishi T; Tomita Y; Hasegawa D; Murashima S; Hirano T; Sakuma H
Ann Nucl Med; 2020 Apr; 34(4):272-279. PubMed ID: 32060780
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
[TBL] [Abstract][Full Text] [Related]
7. Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors.
Sheikhbahaei S; Marcus C; Wray R; Rahmim A; Lodge MA; Subramaniam RM
Nucl Med Commun; 2016 Mar; 37(3):288-96. PubMed ID: 26650959
[TBL] [Abstract][Full Text] [Related]
8. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.
Lasnon C; Desmonts C; Quak E; Gervais R; Do P; Dubos-Arvis C; Aide N
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):985-96. PubMed ID: 23564036
[TBL] [Abstract][Full Text] [Related]
9.
Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312
[TBL] [Abstract][Full Text] [Related]
10. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
Lasnon C; Salomon T; Desmonts C; Dô P; Oulkhouir Y; Madelaine J; Aide N
Ann Nucl Med; 2017 Feb; 31(2):125-134. PubMed ID: 27812791
[TBL] [Abstract][Full Text] [Related]
11. PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor Volume.
Knaup H; Weindler J; van Heek L; Voltin CA; Fuchs M; Borchmann P; Dietlein M; Kobe C; Roth K
Acad Radiol; 2023 Dec; ():. PubMed ID: 38155023
[TBL] [Abstract][Full Text] [Related]
12. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Bardet S; Gervais R; Lemoel G; Zalcman G; Aide N
Clin Nucl Med; 2012 Oct; 37(10):971-6. PubMed ID: 22899197
[TBL] [Abstract][Full Text] [Related]
13. Treatment response assessment in [
Dolci C; Spadavecchia C; Crivellaro C; De Ponti E; Todde S; Morzenti S; Turolla EA; Crespi A; Guerra L; Landoni C
Phys Med; 2019 Jan; 57():177-182. PubMed ID: 30738523
[TBL] [Abstract][Full Text] [Related]
14. Test-Retest Variability in Lesion SUV and Lesion SUR in
Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J
J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598
[TBL] [Abstract][Full Text] [Related]
15. Does PET SUV Harmonization Affect PERCIST Response Classification?
Quak E; Le Roux PY; Lasnon C; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
J Nucl Med; 2016 Nov; 57(11):1699-1706. PubMed ID: 27283930
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and Optimization of a New PET Reconstruction Algorithm, Bayesian Penalized Likelihood Reconstruction, for Lung Cancer Assessment According to Lesion Size.
Otani T; Hosono M; Kanagaki M; Onishi Y; Matsubara N; Kawabata K; Kimura H
AJR Am J Roentgenol; 2019 Aug; 213(2):W50-W56. PubMed ID: 30995096
[No Abstract] [Full Text] [Related]
17. Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values.
Jaskowiak CJ; Bianco JA; Perlman SB; Fine JP
J Nucl Med; 2005 Mar; 46(3):424-8. PubMed ID: 15750154
[TBL] [Abstract][Full Text] [Related]
18. Bayesian penalized likelihood PET reconstruction impact on quantitative metrics in diffuse large B-cell lymphoma.
Young JR; Mugu VK; Johnson GB; Ehman EC; Packard AT; Homb AC; Nathan MA; Thanarajasingam G; Kemp BJ
Medicine (Baltimore); 2023 Feb; 102(6):e32665. PubMed ID: 36820562
[TBL] [Abstract][Full Text] [Related]
19. Novel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules.
Teoh EJ; McGowan DR; Bradley KM; Belcher E; Black E; Gleeson FV
Eur Radiol; 2016 Feb; 26(2):576-84. PubMed ID: 25991490
[TBL] [Abstract][Full Text] [Related]
20. Liver SULmean at FDG PET/CT: interreader agreement and impact of placement of volume of interest.
Viner M; Mercier G; Hao F; Malladi A; Subramaniam RM
Radiology; 2013 May; 267(2):596-601. PubMed ID: 23297330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
